WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1994015615) POTENTIATION OF TEMOZOLOMIDE IN HUMAN TUMOUR CELLS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1994/015615    International Application No.:    PCT/GB1994/000065
Publication Date: 21.07.1994 International Filing Date: 13.01.1994
Chapter 2 Demand Filed:    17.06.1994    
IPC:
A61K 31/52 (2006.01)
Applicants: CANCER RESEARCH CAMPAIGN TECHNOLOGY, LTD. [GB/GB]; Cambridge House, 6-10 Cambridge Terrace, Regent's Park, London NW1 4JL (GB) (For All Designated States Except US).
BAER, John, Colin [GB/GB]; (GB) (For US Only).
FREEMAN, Azadeh, Alison [GB/GB]; (GB) (For US Only).
NEWLANDS, Edward, Stuart [GB/GB]; (GB) (For US Only).
WATSON, Amanda, Jean [GB/GB]; (GB) (For US Only).
RAFFERTY, Joseph, Anthony [GB/GB]; (GB) (For US Only).
MARGISON, Geoffrey, Paul [GB/GB]; (GB) (For US Only)
Inventors: BAER, John, Colin; (GB).
FREEMAN, Azadeh, Alison; (GB).
NEWLANDS, Edward, Stuart; (GB).
WATSON, Amanda, Jean; (GB).
RAFFERTY, Joseph, Anthony; (GB).
MARGISON, Geoffrey, Paul; (GB)
Agent: RITTER, Stephen, David; Mathys & Squire, 100 Grays Inn Road, London WC1X 8AL (GB)
Priority Data:
08/004,754 14.01.1993 US
Title (EN) POTENTIATION OF TEMOZOLOMIDE IN HUMAN TUMOUR CELLS
(FR) AUGMENTATION DE TOXICITE DE TEMOZOLOMIDE DANS LES CELLULES TUMORALES HUMAINES
Abstract: front page image
(EN)The toxicity of temozolomide, an anti-tumour agent useful in the treatment of various mammalian neoplasms, can be potentiated by the prior administration of an ATase inhibiting agent, i.e., O?6¿-benzylguanine.
(FR)La toxicité de la témozolomide qui est un agent anti-tumoral utilisé dans le traitement de divers néoplasmes mammaliens, est augmentée par administration préalable d'un agent inhibiteur de l'ATase, c'est-à-dire de la benzylguanine-O?6¿.
Designated States: AU, BB, BG, BR, BY, CA, CN, CZ, FI, HU, JP, KR, KZ, LK, LV, MG, MN, MW, NO, NZ, PL, PT, RO, RU, SD, SK, UA, US, UZ, VN.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)